Evidence mapPaperPMID 29497341Full record

ArticleClinical Medicine Insights. Cardiology2018

Cardiovascular Risk Factors and Atherogenic Indices in an Iranian Population: Birjand East of Iran.

Toba Kazemi, Morteza Hajihosseini, Maryam Moossavi, Mina Hemmati, Masood Ziaee

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Clinical Medicine Insights. Cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT03693560. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03693560 phase4completed

The Effect of Adding Vildagliptin Versus Glimepiride to Metformin on Markers of Inflammation, Thrombosis, and Atherosclerosis in Diabetic Patients With Symptomatic Coronary Artery Diseases

Ran2018Enrolled80Registered outcomes7Posted comparisons0ConditionsCoronary Artery Disease, Diabetes Mellitus, Type 2ArmsGlimepiride upto 4 mg Oral Tablet, Metformin 1000 mg Oral Tablet, Vildagliptin 50 mg Oral Tablet
Open the trial in the graph
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Protective Effects ofFood science & nutrition · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Effects of Cinnamon (Nutrients · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Toba KazemiCardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Morteza HajihosseiniCardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Maryam MoossaviStudent Research Committee, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Mina HemmatiCardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Masood ZiaeeInfectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Birjand University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Atherogenic indexcardiovascular diseasecoronary risk indexlipid profile

Identifiers

PMID29497341
PMCPMC5824902
OpenAlexW2793623478

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.